Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study

PURPOSE: We aimed to evaluate the efficacy and safety of the use of docetaxel plus androgen deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC) in Korean patients. MATERIALS AND METHODS: This study was conducted retrospectively. In total, 61 Korean patients with mHSPC...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Investig Clin Urol
Hlavní autoři: Kwon, Whi-An, Joung, Jae Young, Lee, Jung Eun, Choi, Se Young, Kim, Sung Han, Seo, Ho Kyung, Lee, Kang Hyun, Kim, Choung-Soo
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Urological Association 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6495039/
https://ncbi.nlm.nih.gov/pubmed/31098427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.2019.60.3.195
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky